Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
30.57
-1.85 (-5.71%)
At close: Jul 10, 2026, 4:00 PM EDT
30.57
0.00 (0.00%)
After-hours: Jul 10, 2026, 4:34 PM EDT
Maze Therapeutics Employees
Maze Therapeutics had 141 employees as of December 31, 2025. The number of employees increased by 16 or 12.80% compared to the previous year.
Employees
141
Change (1Y)
16
Growth (1Y)
12.80%
Revenue / Employee
$141,844
Profits / Employee
-$869,092
Market Cap
1.69B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 141 | 16 | 12.80% |
| Dec 31, 2024 | 125 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Immunocore Holdings | 524 |
| Vir Biotechnology | 367 |
| UroGen Pharma | 298 |
| Zenas BioPharma | 167 |
| Innoviva | 159 |
| Absci | 140 |
| MapLight Therapeutics | 133 |
| Septerna | 130 |
MAZE News
- 4 weeks ago - Maze Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - Maze Therapeutics Transcript: AGM 2026 - Transcripts
- 5 weeks ago - Maze Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 5 weeks ago - Maze Therapeutics Slides: Investor presentation - Filings
- 6 weeks ago - Maze Therapeutics to Participate in Two Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Maze Therapeutics reports Q1 EPS (45c), consensus (63c) - TheFly
- 2 months ago - Maze Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights - GlobeNewsWire
- 2 months ago - Maze Therapeutics Earnings release: Q1 2026 - Filings